<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Triglycerides and carotid intima-media thickness in ischemic stroke patients</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-09-09">9 September 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Jana</forename><surname>Batluk</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Stroke Research Berlin (CSB)</orgName>
								<orgName type="institution">Charit e e Universit€ atsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Christopher</forename><forename type="middle">O</forename><surname>Leonards</surname></persName>
							<email>christopher.leonards@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Center for Stroke Research Berlin (CSB)</orgName>
								<orgName type="institution">Charit e e Universit€ atsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ulrike</forename><surname>Grittner</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Stroke Research Berlin (CSB)</orgName>
								<orgName type="institution">Charit e e Universit€ atsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department for Biostatistics and Clinical Epidemiology</orgName>
								<orgName type="institution">Charit e e Universit€ atsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kristin</forename><forename type="middle">Sophie</forename><surname>Lange</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Stroke Research Berlin (CSB)</orgName>
								<orgName type="institution">Charit e e Universit€ atsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephan</forename><forename type="middle">J</forename><surname>Schreiber</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Klinik und Hochschulambulanz für Neurologie</orgName>
								<orgName type="institution">Charit e e Universit€ atsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Matthias</forename><surname>Endres</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Stroke Research Berlin (CSB)</orgName>
								<orgName type="institution">Charit e e Universit€ atsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Klinik und Hochschulambulanz für Neurologie</orgName>
								<orgName type="institution">Charit e e Universit€ atsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Excellence Cluster NeuroCure</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">German Center of Neurodegenerative Diseases (DZNE)</orgName>
								<orgName type="institution">Charit e e Universit€ atsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">German Center for Cardiovascular Research (DZHK)</orgName>
								<address>
									<addrLine>Charit e</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Martin</forename><surname>Ebinger</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Stroke Research Berlin (CSB)</orgName>
								<orgName type="institution">Charit e e Universit€ atsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Klinik und Hochschulambulanz für Neurologie</orgName>
								<orgName type="institution">Charit e e Universit€ atsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="institution">versit€ atsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Mitte, Charit e Platz 1</addrLine>
									<postCode>D-10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Triglycerides and carotid intima-media thickness in ischemic stroke patients</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-09-09">9 September 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">376C341AABB1FF6334F7A10FF99859A5</idno>
					<idno type="DOI">10.1016/j.atherosclerosis.2015.09.003</idno>
					<note type="submission">Received 9 September 2014 Received in revised form 26 August 2015 Accepted 3 September 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:50+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>Glucose Triglycerides Intima-media thickness Acute stroke Ultrasonography</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Common carotid artery intima-media thickness (CCA-IMT) is an established marker for atherosclerosis.</s><s>The role of triglycerides in CCA-IMT remains controversial.</s><s>We sought to determine if elevated fasting and post-challenge triglycerides are associated with CCA-IMT.</s><s>Methods: All acute ischemic stroke patients who participated in the Berlin "Cream &amp; Sugar" study in the Charit e Virchow and Charit e Mitte Campuses between January 2009 and January 2014 and underwent carotid artery ultrasound studies were eligible for inclusion.</s><s>A combined oral glucose and triglyceride tolerance test was performed 3e7 days after first ever ischemic stroke.</s><s>Patients were classified according to triglyceride metabolismdnamely, (1) patients reaching a maximum triglyceride levels 3 h postchallenge ("fast metabolizers," n ¼ 37), (2) patients with increasing triglycerides 4 (medium metabolizers, n ¼ 64), and (3) 5 h post-challenge ("slow metabolizers," n ¼ 44; 13 missing).</s><s>Results: We included 158 patients (34% female; mean age 63 years, SD 14).</s><s>Absolute non-fasting triglyceride levels were positively associated with CCA-IMT.</s><s>A final multiple regression model revealed that older age, more severe strokes, and higher levels of fasting triglycerides were significantly and independently associated with higher mean CCA-IMT.</s><s>Older age, higher waist-to-hip ratio, and higher levels of thyroid-stimulating hormone were independently associated with higher maximum CCA-IMT.</s><s>Conclusion: Fasting triglycerides but not post-challenge triglycerides associate with CCA-IMT.</s><s>An oral fat challenge may not add information on atherosclerotic status in ischemic stroke patients.</s><s>Clinical Trial Registration Information: The Berlin "Cream &amp; Sugar" study is registered with EudraCT (2009-010356-97) and clinicaltrials.gov</s><s>(NCT 01378468).</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p><s>Common carotid artery intima-media thickness (CCA-IMT) is an established marker of atherosclerosis <ref type="bibr" target="#b0">[1]</ref> and ischemic stroke risk <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b2">3]</ref>.</s><s>Though impaired postprandial triglyceride clearance has long been thought to contribute to coronary atherosclerosis [4e6], surprisingly few studies have directly investigated the relationship between CCA-IMT and triglyceride metabolism <ref type="bibr">[7e11]</ref>.</s></p><p><s>Results from studies that have assessed the relationship between absolute triglycerides and CCA-IMT have been mixed.</s><s>Some studies have found positive relationships to exist between CCA-IMT and postprandial [7e10] or fasting triglycerides <ref type="bibr">[12e14]</ref>.</s><s>Others have found no association to exist between CCA-IMT and fasting [15e17] or post-challenge triglycerides <ref type="bibr" target="#b10">[11]</ref>.</s></p><p><s>To date, most trials assessing triglyceride reduction strategies in patients with high cardiovascular risk profiles have used fasting levels when screening patients for inclusion <ref type="bibr">[18e20]</ref>.</s><s>However, evidence from large epidemiological studies shows that nonfasting triglycerides are likely more indicative of cardiovascular risk <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b21">22]</ref>.</s><s>Therefore, it is possible that patient samples in trials with triglyceride lowering endpoints have not been optimally selected, which has led to the suggestion that implementing a standardized oral triglyceride tolerance test may be beneficial when screening patients for cardiovascular/stroke risk <ref type="bibr" target="#b22">[23]</ref>.</s></p><p><s>We sought to determine if fasting and post-challenge triglycerides associate with CCA-IMT in ischemic stroke patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1.">Participants</head><p><s>The Berlin "Cream &amp; Sugar" study (NCT 01378468) is an ongoing prospective cohort study with the purpose of determining if postchallenge triglycerides associate with recurrent stroke.</s><s>Detailed methods have been presented elsewhere <ref type="bibr" target="#b23">[24]</ref>.</s><s>Briefly, we screened all suspected stroke patients within 3e7 days of symptom onset who were over 18 years of age and were admitted to one of three university campus hospitals in Berlin (Charit e Mitte, Virchow, and Benjamin Franklin campuses).</s><s>First ever acute ischemic stroke patients who were capable of participating in an oral triglyceride and glucose tolerance test were eligible for inclusion.</s></p><p><s>Ischemic stroke was defined as a focal neurological deficit lasting for at least 24 h with no signs of hemorrhage on cerebral imaging.</s><s>All strokes were verified radiologically using diffusionweighted images.</s><s>First ever ischemic stroke was defined based on relevant medical history disregarding potential "silent" strokes on cerebral imaging that may have occurred prior to study enrollment.</s><s>Stroke severity was assessed on hospital admission and on the day of testing (3e7 days after symptom onset) using the National Institute of Health Stroke Scale (NIHSS).</s><s>Stroke was categorized according to a mechanism-based classification scheme (Trial of ORG 10172 in Acute Stroke Treatment, or TOAST) <ref type="bibr" target="#b24">[25]</ref>.</s><s>All patients provided informed consent and the study was approved by the local ethics committee.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.">Blood samples</head><p><s>Baseline data and venous blood samples were collected after participants had provided informed consent and fasted overnight for !10 h.</s><s>Fasting blood samples were drawn at 8 AM, followed by a combined oral triglyceride and glucose tolerance test (oTTT/oGTT).</s><s>The oTTT consisted of ingesting 250 mL of 32% fat cream within 30 min and took place immediately after the 8 AM fasting blood draw.</s><s>At 11 AM, all patients provided venous blood samples and if no known diabetes was present, patients then immediately drank 75 g of Dextrose mixed in 250 mL of water (oral glucose tolerance test).</s><s>Further venous blood samples were collected at 12 PM and 1 PM.</s><s>Triglyceride and cholesterol concentrations were determined in freshly drawn venous blood samples enzymatically using a Cobas 6000 analyzer (Roche/Hitachi).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.">Common carotid artery intima-media thickness</head><p><s>In this Berlin "Cream &amp; Sugar" substudy, we searched our clinical database for CCA ultrasound images archived in the Virchow and Mitte Campuses.</s><s>CCA ultrasounds were performed by our clinical neurology sonography lab using B-mode ultrasonography with the Acuson X300 (Siemens Healthcare, Germany; Virchow) and the Toshiba PowerVision 6000 (Toshiba, Japan; Mitte) 7.5 MHz high-resolution annular array scanner.</s><s>All patients were evaluated in the supine position with the head turned 45 to the contralateral side of the artery being examined.</s><s>One rater (KSL) evaluated CCA-IMT using the ImageJ software package (National Institute of Health, Baltimore, Md) <ref type="bibr" target="#b25">[26]</ref>.</s><s>Both the right and left CCA were evaluated.</s><s>All measurements were performed in accordance with the "Mannheim carotid intima-media thickness consensus" (2004e2006) <ref type="bibr" target="#b26">[27]</ref>.</s><s>The region of interest (ROI) for CCA-IMT assessment was defined as at least a 10 mm plaque-free portion of the CCA far-wall at least 10 mm before the bifurcation.</s><s>As illustrated in Fig. <ref type="figure" target="#fig_0">1</ref>, to determine CCA-IMT, we measured the distance between the first hyperechogenic line (border between vessel lumen and intima, yellow line in Fig. <ref type="figure" target="#fig_0">1</ref>) and the second hyperechogenic line (mediaeadventitia border, pink line in Fig. <ref type="figure" target="#fig_0">1</ref>) of the CCA far wall.</s><s>To assess associations between various patient characteristics and CCA-IMT, we used aggregated values per patient using two different aggregation methods: (1) maximum recorded CCA-IMT value (i.e. if the right CCA-IMT was larger than the left CCA-IMT, the right CCA-IMT value was used) and (2) mean CCA-IMT value of the right and left CCA.</s><s>The number of heart cycles and time-point within the heart cycle was not taken into consideration.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.">Definitions and calculations</head><p><s>Diabetes was defined as current use of anti-diabetic medication or serum glycosylated hemoglobin (HbA1C) of &gt;6.5%.</s><s>Hypertension was defined as current antihypertensive medication use.</s><s>Glomerular filtration rate was estimated using the Modification of Diet and Renal Diseases formula <ref type="bibr" target="#b27">[28]</ref>.</s><s>Adjusted triglyceride levels for 3, 4, and 5 h post-challenge (aTG3, aTG4, aTG5) were defined here as the triglyceride values at 3, 4, and 5 h post-challenge minus the fasting triglyceride value (TG0) respectively (e.g.</s><s>aTG3 ¼ TG3 À TG0).</s><s>Peak triglyceride response refers to the maximum triglyceride level obtained minus TG0.</s><s>Triglyceride area under the curve (AUC) and incremental area under the curve (iAUC; relative to fasting triglyceride values) were calculated using the trapezoidal integration method.</s><s>"Fast" triglyceride metabolizers was defined here as having triglyceride values that rose sharply from 0 to 3 h postchallenge and thereafter declined.</s><s>"Medium" triglyceride metabolism was defined as having reached maximum triglyceride values between 3 and 4 h post-challenge.</s><s>"Slow" triglyceride metabolism indicates triglyceride levels that rose until 5 h post-challenge.</s><s>For all metabolism categories (fast, medium, and slow), a "rise" in triglyceride levels (or "maximum" triglyceride level) was defined as a &gt;10% increase in triglyceride values from one consecutive timepoint to the next (e.g.</s><s>fasting to 3 h post-challenge; 3 he4 h postchallenge, and 4e5 h post-challenge).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5.">Statistical analysis</head><p><s>To present bivariate descriptive characteristics, CCA-IMT (dependent variable) was stratified into tertiles (three equal groups) and ordinal regression analyses were performed using individual continuous variables separately as independent variables (Table <ref type="table" target="#tab_0">1</ref>).</s><s>Non-normally distributed variables were logtransformed (log 10) to reduce skewness before analyses.</s><s>To test differences in CCA-IMT between different categorical characteristics ManneWhitney-Test or KruskaleWallis-Test was used (Table <ref type="table" target="#tab_1">2</ref>).</s><s>With regard to ordinal characteristics, ordinal regression analyses were performed with the ordinal variable set as the dependent variable.</s><s>Post hoc pairwise comparisons among estimated marginal means (adjusted for age categories) were conducted to assess differences in CCA-IMT with regard to triglyceride metabolism.</s><s>Variables significant at the a-level of 0.10 in bivariate analysis were included into a backwards stepwise multiple linear regression analysis with log-transformed CCA-IMT as dependent variable.</s><s>Collinearity was assessed by calculating tolerance (considered significant if &lt; 0.2) and variance inflation factor (considered relevant collinearity if &gt; 5).</s><s>All statistical analyses were performed with SPSS 22 (SPSS Inc., Chicago, USA).</s><s>All tests were 2sided and, unless otherwise stated, relationships were considered significant at an a-level of 0.05.</s><s>No adjustment for multiple testing was applied.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Results</head><p><s>We included 158 patients in this Berlin "Cream &amp; Sugar" substudy (please see Supplemental Figure <ref type="figure" target="#fig_0">S1</ref> for overall summary of "Cream &amp; Sugar" sample size during screening, inclusion/exclusion, and analysis for this sub-study).</s><s>In comparison with the overall Cream &amp; Sugar study cohort, the patient sample included in this sub-study was significantly younger (median 65 years, IQR: 51e73; remaining C&amp;S cohort: median 68 years, IQR: 57e75; Man-neWhitney U: p ¼ 0.018), had lower serum creatinine values (included: median 0.88 mg/dL, IQR: 74e1.01;</s><s>remaining C&amp;S cohort: median 0.94 mg/dL, IQR: 0.8e1.05;</s><s>ManneWhitney U: For mean CCA-IMT values, backwards stepwise multiple linear regression analysis (which included 82 patients) that tested for variables significant at an a-level of 0.10 in bivariate analysisdi.e., age, stroke severity (according to NIHSS), waist-to-hip ratio, systolic blood pressure, estimated glomerular filtration rate (according to MDRD), stroke subtype (according to TOAST classification), triglyceride metabolism, statins, and ace inhibitor medicationdrevealed associations between higher mean CCA-IMT (i.e.</s><s>mean of left and right CCA, log-transformed) and older age (unstandardized b ¼ 0.0003, p &lt; 0.001), more severe strokes (logtransformed NIHSS, unstandardized b ¼ 0.035, p ¼ 0.015), and higher levels of fasting triglycerides (log-transformed, unstandardized b ¼ 0.012, p ¼ 0.018).</s><s>Only these three covariates remained in the final model.</s><s>No evidence for collinearity was found.</s></p><p><s>For maximum CCA-IMT values (log-transformed), backwards stepwise multiple linear regression analysis (which included 127 patients) that tested for variables significant at an a-level of 0.10 in bivariate analysisdi.e., age, waist-to-hip ratio, CRP, estimated glomerular filtration rate (according to MDRD), thyroid-stimulating hormone, insulin resistance (according to HOMA), and stroke subtype (according to TOAST classification)drevealed that higher maximum CCA-IMT values (log-transformed) were associated with older age (unstandardized b ¼ 0.004, p &lt; 0.001), higher waist-tohip ratio (log-transformed, unstandardized b ¼ 0.475, p ¼ 0.023), and higher levels of thyroid-stimulating hormone (log-transformed, unstandardized b ¼ 0.082, p ¼ 0.042).</s><s>Only the variables with reported regression coefficients remained in the final model.</s><s>No evidence for collinearity was identified.</s></p><p><s>We additionally analyzed parameters associated with plaque presence (present vs. not present).</s><s>Retrospective analysis showed that plaque presence was associated with higher HbA1c (present: median HbA1c 5.7%, IQR 5.4e6.3;</s><s>not present: median HbA1c 5.3%, IQR 5.0e5.6,</s><s>ManneWhitney U test, p ¼ 0.001), waist-to-hip ratio (plaques: median 0.98, IQR 0.95e1.03;</s><s>no plaques: median 0.94, IQR 0.88e0.99,</s><s>ManneWhitney U test, p ¼ 0.027), 5-h postchallenge triglycerides (plaques: median 246 mg/dL, IQR 166e356; no plaques: median 214 mg/dL, IQR 110e255, Man-neWhitney U test, p ¼ 0.05), fasting glucose (plaques: median 98 mg/dL, IQR 88e113; no plaques: median 88 mg/dL, IQR 85e95, ManneWhitney U test, p ¼ 0.003).</s><s>Additionally, plaques presence was significantly associated with a lower estimate glomerular filtration rate (plaques: median 84 mL/min, IQR 71e97; no plaques: median 103 mL/min, IQR 84e111, ManneWhitney U test, p ¼ 0.009)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Discussion</head><p><s>The main finding of this study was that fasting triglycerides independently and positively associated with mean CCA-IMT in acute ischemic stroke patients.</s><s>This contributes to the current literature as it extends the observation that though the link between absolute triglyceride levels (whether fasting or non-fasting) may be tenuous, triglyceride exposure seems to play at least an associative role in atherogenesis.</s><s>Based on these results however, we cannot recommend using an oral triglyceride tolerance test to identify patients at high risk for atherosclerosis.</s></p><p><s>Currently, the understanding is that circulating triglycerides largely arise from dietary fat intake <ref type="bibr" target="#b28">[29]</ref>.</s><s>Traditionally not considered to be atherogenic due to their large size, more recent findings in mice genetically bread to be incapable of performing lipolysis on the luminal side of the endothelium have shown that chylomicronemia (and resultant severe hypertriglyceridemia) leads to atherosclerotic lesions <ref type="bibr" target="#b29">[30]</ref>.</s><s>It remains unclear why this is the case, though it has been speculated that macrophages and proinflammatory factors may play a contributing role <ref type="bibr" target="#b30">[31]</ref>.</s><s>Additionally, in humans, it has been proposed that prolonged exposure to elevated triglycerides may alter endothelial metabolism and predispose for atherosclerotic changes <ref type="bibr" target="#b31">[32]</ref>.</s><s>Though we found that fasting triglycerides associate with atherosclerotic burden in the CCA, our findings oppose this newer theory that prolonged postchallenge triglyceride exposure is associated with CCA-IMT.</s></p><p><s>Recently published results from the Homburg Cream and Sugar study <ref type="bibr" target="#b32">[33]</ref> augment our findings.</s><s>Using identical oral triglyceride tolerance test methods in patients with coronary artery disease, Werner et al. found that elevated serum triglycerides (fasting and area under the curve) independently associated with cardiovascular events.</s><s>Similarly, Werner et al. found that post-challenge triglycerides were not superior to fasting triglycerides in outcome prediction models.</s><s>Akin to these findings, we observed that initial stroke severity (assessed using the NIHSS scale) and fasting triglycerides associated independently with CCA-IMT in ischemic stroke patients.</s></p><p><s>Additionally, Schmidt-Trucks€ ass et al. <ref type="bibr" target="#b33">[34]</ref> found that certain triglyceride profiles tended to be atherogenic in that they had higher LDL and lower HDL cholesterol.</s><s>Specifically, they classified patients as: Group 1 ("low risk"), patients who had both fasting and post-challenge triglycerides of &lt;200 mg/dL; Group 2 ("moderate risk"), patients with fasting triglycerides &lt;200 mg/dL and maximum post-challenge triglycerides &gt;200 mg/dL; and Group 3 ("high risk"), patients whose fasting and maximum post-challenge triglycerides were &gt;200 mg/dL.</s><s>We retrospectively stratified our patients according to this scheme and found that although none of the groups associated with CCA-IMT or carotid plaques (data not shown), there was a positive linear association between the triglyceride groups and LDL (ordinal regression, LDL log transformed, unstandardized beta 0.011, p ¼ 0.031) and total cholesterol (ordinal regression, unstandardized beta 0.012, p ¼ 0.006).</s><s>This stratification of triglycerides warrants further investigation as it may pertain to functional stroke outcome and recurrent stroke.</s></p><p><s>It has been speculated that vascular risk might be best assessed 3e4 h (i.e. during peak time points) following a triglyceride tolerance test <ref type="bibr" target="#b22">[23]</ref>.</s><s>We observed that post-challenge triglyceride concentrations increased similarly in all patients until roughly the 4 h post-challenge time-points.</s><s>These findings akin to those of Groot et al. <ref type="bibr" target="#b3">[4]</ref>, who measured triglyceride concentrations for 24 h following an oral triglyceride tolerance test in patients with and without coronary artery disease.</s><s>Although Groot et al. <ref type="bibr" target="#b3">[4]</ref> reported an association between coronary artery disease and 8 h triglycerides and later, graphical representation revealed that the groups began to deviate between the 4 and 5 h time-points (though not of statistical significance).</s></p><p><s>This study has limitations.</s><s>First, because of Berlin "Cream &amp; Sugar" Study inclusion criteria, there was a selection bias for mildly affected stroke patients (median NIHSS 1; range 0e13).</s><s>Second, men were overrepresented (71%).</s><s>Third, our study sample was relatively small and our cross-sectional approach limits our ability to identify a cause-effect relationship between triglyceride metabolism and CCA-IMT.</s><s>Larger, longitudinal studies are needed to assess the possible relationship we found here.</s><s>Fourth, we did not take the time-point of CCA-IMT measurement during the heart cycle into account.</s><s>Finally, a large number of patients were taking statins (51%), which may have influenced our lipid metabolism parameters.</s><s>However, we controlled for statin use in multiple models and the relationship between CCA-IMT and fasting triglycerides remained significant.</s></p><p><s>In conclusion, we found that fasting serum triglycerides positively and independently associate with CCA-IMT.</s><s>Post-challenge triglycerides however, were not associated with CCA-IMT.</s><s>The novel combined oral glucose and triglyceride tolerance test was not efficacious in selecting patients with increased atherosclerotic burden.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc><div><p><s>Fig. 1.</s><s>Ultrasound and schematic representation of the common carotid artery.</s><s>In the schematic representation, the yellow line represents the luminal intima and the pink line represents the adventitia.</s><s>The space between the adventitia and intima on the far wall of the CCA is defined here as the intima-media thickness.</s><s>CCA indicates common carotid artery; IMT, intima-media thickness; ROI, region of interest; min, minimum; mm, millimeters.</s><s>(For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)</s></p></div></figDesc><graphic coords="2,313.68,368.22,246.72,307.28" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Baseline characteristics of continuous variables according to mean (of right and left artery) common carotid intima-media thickness tertiles.</s></p></div></figDesc><table><row><cell></cell><cell>IMT &lt; 0.68 mm (n ¼ 39)</cell><cell>0.68 IMT 0.87 mm (n ¼ 39)</cell><cell>IMT &gt; 0.87 mm (n ¼ 39)</cell><cell>p</cell></row><row><cell>Age, y (0 missing) a</cell><cell>54 (16)</cell><cell>64 (15)</cell><cell>68 (12)</cell><cell>&lt;0.001</cell></row><row><cell>NIHSS (9 missing) b</cell><cell>1 (0e2)</cell><cell>1 (0e2)</cell><cell>2 (1e3)</cell><cell>0.013</cell></row><row><cell>BMI (1 missing) b</cell><cell>26 (22e29)</cell><cell>27 (25e29)</cell><cell>27 (23e29)</cell><cell>0.606</cell></row><row><cell>WHR (13 missing) b</cell><cell>0.97 (0.89e1.02)</cell><cell>0.99 (0.95e1.02)</cell><cell>1.02 (0.96e1.07)</cell><cell>0.011</cell></row><row><cell>sBP, mmHg (8 missing) a</cell><cell>129 (20)</cell><cell>137 (24)</cell><cell>137 (14)</cell><cell>0.089</cell></row><row><cell>dBP, mmHg (8 missing) b</cell><cell>75 (70e81)</cell><cell>77 (70e89)</cell><cell>75 (70e85)</cell><cell>0.655</cell></row><row><cell>CRP, mg/dL (5 missing) b</cell><cell>0.3 (0.1e0.7)</cell><cell>0.7 (0.1e2.7)</cell><cell>0.7 (0.2e1.4)</cell><cell>0.118</cell></row><row><cell>eGFR, mL/min (4 missing) b</cell><cell>97 (88e111)</cell><cell>83 (75e96)</cell><cell>81 (72e91)</cell><cell>0.058</cell></row><row><cell>TSH mlU/ml (2 missing) b</cell><cell>1.7 (1.1e2.6)</cell><cell>1.6 (1.1e2.6)</cell><cell>1.9 (1.3e2.9)</cell><cell>0.456</cell></row><row><cell>TChol mmol/L (2 missing) a</cell><cell>4.6 (0.9)</cell><cell>5.1 (1.0)</cell><cell>4.7 (1.2)</cell><cell>0.563</cell></row><row><cell>HDL, mmol/L (2 missing) b</cell><cell>1.2 (1.1e1.6)</cell><cell>1.2 (1.1e1.5)</cell><cell>1.2 (1.1e1.4)</cell><cell>0.924</cell></row><row><cell>LDL, mmol/L (2 missing) a</cell><cell>2.7 (0.7)</cell><cell>3.2 (1.0)</cell><cell>2.8 (1.0)</cell><cell>0.978</cell></row><row><cell>ALAT, U/l (4 missing) b</cell><cell>26 (17e42)</cell><cell>24 (21e43)</cell><cell>24 (18e38)</cell><cell>0.573</cell></row><row><cell>HbA1c, % (3 missing) b</cell><cell>5.4 (5.3e5.8)</cell><cell>5.8 (5.3e6.2)</cell><cell>5.8 (5.5e6.2)</cell><cell>0.197</cell></row><row><cell>GLC0, mmol/L (2 missing) b</cell><cell>5.0 (4.7e5.8)</cell><cell>5.2 (4.7e6.1)</cell><cell>5.5 (4.9e5.8)</cell><cell>0.116</cell></row><row><cell>GLC3, mmol/L (4 missing) b</cell><cell>5.1 (4.6e5.5)</cell><cell>5.1 (4.6e6.1)</cell><cell>5.0 (4.9e5.5)</cell><cell>0.125</cell></row><row><cell>GLC4, mmol/L (8 missing) b</cell><cell>7.2 (5.5e9.5)</cell><cell>8.2 (5.9e9.8)</cell><cell>8.0 (5.4e10.0)</cell><cell>0.601</cell></row><row><cell>GLC5, mmol/L (7 missing) b</cell><cell>6.4 (4.9e8.1)</cell><cell>6.1 (5.4e8.6)</cell><cell>6.4 (4.8e9.9)</cell><cell>0.637</cell></row><row><cell>Insulin 0, pmol/L (10 missing) b</cell><cell>49 (35e78)</cell><cell>56 (35e83)</cell><cell>66 (42e102)</cell><cell>0.076</cell></row><row><cell>Insulin 3, pmol/L (4 missing) b</cell><cell>69 (42e104)</cell><cell>69 (49e108)</cell><cell>83 (63e122)</cell><cell>0.101</cell></row><row><cell>Insulin 4, pmol/L (12 missing) b</cell><cell>281 (160e483)</cell><cell>274 (102e424)</cell><cell>285 (104e646)</cell><cell>0.814</cell></row><row><cell>Insulin 5, pmol/L (15 missing) b</cell><cell>188 (111e438)</cell><cell>184 (111e326)</cell><cell>285 (83e538)</cell><cell>0.637</cell></row><row><cell>HOMA (11 missing) b</cell><cell>1.5 (1.0e2.7)</cell><cell>1.8 (1.3e3.4)</cell><cell>2.4 (1.5e3.8)</cell><cell>0.037</cell></row><row><cell>TG0, mmol/L (2 missing) b</cell><cell>1.2 (0.9e1.4)</cell><cell>1.3 (1.0e1.6)</cell><cell>1.2 (1.0e1.7)</cell><cell>0.083</cell></row><row><cell>TG3, mmol/L (4 missing) b</cell><cell>2.1 (1.5e2.9)</cell><cell>2.1 (1.5e3.1)</cell><cell>2.4 (1.5e3.1)</cell><cell>0.140</cell></row><row><cell>TG4, mmol/L (6 missing) b</cell><cell>2.5 (2.1e3.3)</cell><cell>3.1 (1.7e4.0)</cell><cell>2.5 (1.6e3.8)</cell><cell>0.870</cell></row><row><cell>TG5, mmol/L (8 missing) b</cell><cell>2.6 (2.0e3.0)</cell><cell>2.9 (1.7e3.7)</cell><cell>2.5 (1.4e3.9)</cell><cell>0.892</cell></row><row><cell>TGmax, mmol/L (1 missing) b</cell><cell>2.8 (2.2e3.4)</cell><cell>3.1 (1.9e4.0)</cell><cell>2.7 (1.7e4.1)</cell><cell>0.871</cell></row><row><cell>Peak TGr, mmol/L (2 missing) b</cell><cell>1.4 (1.0e2.3)</cell><cell>1.5 (0.8e2.4)</cell><cell>1.4 (0.7e2.6)</cell><cell>0.384</cell></row><row><cell>TG AUC (1 missing) b</cell><cell>9.7 (6.9e12.2)</cell><cell>10.6 (6.8e14.4)</cell><cell>10.7 (6.9e14.7)</cell><cell>0.221</cell></row><row><cell>TG iAUC (5 missing) b</cell><cell>3.7 (2.3e5.0)</cell><cell>3.6 (1.7e4.8)</cell><cell>3.6 (1.9e6.6)</cell><cell>0.838</cell></row><row><cell>transformed.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>ALAT indicates alanine aminotransferase; BMI, body mass index; CRP, c-reactive protein; dBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; GLC0-4, glucose level (0, fasting; 3, 3 h post-challenge; 4, 4 h post-challenge; 5, 5 h post-challenge); HbA1c, glycosylated hemoglobin; HDL, high density lipoprotein; HOMA, Homeostasis Model Assessment; IMT, common carotid intima-media thickness; LDL, low density lipoprotein; mg/dL, milligrams per deciliter; min, minute; mL, milliliters; mm, millimeters; mmHg, millimeter of mercury; mmol/L, millimoles per Liter; NIHSS, National Institutes of Health Stroke Scale; Peak TGr, peak triglyceride response (¼triglyceride maximum e fasting triglyceride); WHR, TG0eTG5, triglycerides (0, fasting; 3, 5 indicate number of hours post-challenge); TG AUC, triglyceride area under the curve; TG iAUC, triglyceride incremental area under the curve; waist-to-hip ratio.a</s><s>Covariate normally distributed.</s><s>Values reported are mean (standard deviation); p-values generated from ordinal regression analysis.</s><s>b Covariate not normally distributed.</s><s>Values reported are median (interquartile range); p-values generated from ordinal regression analysis with covariate log 10 (included: median 133 mg/dL, IQR: 75e207; remaining C&amp;S cohort: median 101 mg/dL, IQR: 58e104; ManneWhitney U: p &lt; 0.001), lower statin use (45% included vs. 62% cohort; Chi Squared: p ¼ 0.003), and tended to have lower hypertension rates (55% included vs. 64% cohort; Chi Squared: p ¼ 0.063).</s><s>No other significant differences in baseline characteristics were observed.</s><s>The mean age of patients included in this sub-study (n ¼ 158;</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s>Baseline characteristics of categorical variables across mean (of right and left artery) common carotid intima-media thickness values.</s></p></div></figDesc><table><row><cell></cell><cell>IMT, median (IQR)</cell><cell>p</cell></row><row><cell>Gender (0 missing)</cell><cell></cell><cell>0.473 a</cell></row><row><cell>Men (n ¼ 80)</cell><cell>0.78 (0.66e0.99)</cell></row><row><cell>Women (n ¼ 37)</cell><cell>0.76 (0.60e0.88)</cell></row><row><cell>Hypertension (0 missing)</cell><cell></cell><cell>0.260 a</cell></row><row><cell>Yes (n ¼ 60)</cell><cell>0.79 (0.68e0.90)</cell></row><row><cell>No (n ¼ 54)</cell><cell>0.76 (0.59e0.93)</cell></row><row><cell>Diabetes (0 missing)</cell><cell></cell><cell>0.491 a</cell></row><row><cell>Yes (n ¼ 21)</cell><cell>0.81 (0.71e0.90)</cell></row><row><cell>No (n ¼ 96)</cell><cell>0.77 (0.61e0.94)</cell></row><row><cell>Alcohol intake (27 missing)</cell><cell></cell><cell>0.299 b</cell></row><row><cell>Never (n ¼ 45)</cell><cell>0.78 (0.68e0.97)</cell></row><row><cell>3x/week (n ¼ 15)</cell><cell>0.86 (0.61e1.05)</cell></row><row><cell>&gt;3x/week (n ¼ 7)</cell><cell>0.53 (0.44e0.86)</cell></row><row><cell>Daily (n ¼ 23)</cell><cell>0.74 (0.64e0.90)</cell></row><row><cell>Smoking status (1 missing)</cell><cell></cell><cell>0.507 b</cell></row><row><cell>Current smokers (n ¼ 41)</cell><cell>0.81 (0.65e0.97)</cell></row><row><cell>Ex-smokers (n ¼ 17)</cell><cell>0.71 (0.63e0.87)</cell></row><row><cell>Never smoked (n ¼ 58)</cell><cell>0.79 (0.65e1.02)</cell></row><row><cell>CAD (9 missing)</cell><cell></cell><cell>0.684</cell></row><row><cell>Yes (n ¼ 3)</cell><cell>0.86 (0.66-NA)</cell></row><row><cell>No (n ¼ 105)</cell><cell>0.76 (0.60e0.88)</cell></row><row><cell>TOAST (2 missing)</cell><cell></cell><cell>0.004 c</cell></row><row><cell>Macroangiopathic (n ¼ 27)</cell><cell>0.88 (0.76e1.02)</cell></row><row><cell>Cardioembolic (n ¼ 25)</cell><cell>0.76 (0.60e0.82)</cell></row><row><cell>Microangiopathic (n ¼ 20)</cell><cell>0.90 (0.69e1.19)</cell></row><row><cell>Other cause (n ¼ 10)</cell><cell>0.60 (0.50e0.82)</cell></row><row><cell>Unknown (n ¼ 33)</cell><cell>0.71 (0.64e0.84)</cell></row><row><cell>Statins (0 missing)</cell><cell></cell><cell>0.067 a</cell></row><row><cell>Yes (n ¼ 57)</cell><cell>0.83 (0.66e1.01)</cell></row><row><cell>No (n ¼ 60)</cell><cell>0.74 (0.60e0.84)</cell></row><row><cell>ACE inhibitors (0 missing)</cell><cell></cell><cell>0.087 a</cell></row><row><cell>Yes (n ¼ 21)</cell><cell>0.86 (0.76e1.02)</cell></row><row><cell>No (n ¼ 96)</cell><cell>0.76 (0.62e0.93)</cell></row><row><cell>ARA II (0 missing)</cell><cell></cell><cell>0.422 a</cell></row><row><cell>Yes (n ¼ 6)</cell><cell>0.84 (0.66e1.10)</cell></row><row><cell>No (n ¼ 111)</cell><cell>0.78 (0.66e1.10)</cell></row><row><cell>Antihypertensives (0 missing)</cell><cell></cell><cell>0.701 c</cell></row><row><cell>None (n ¼ 83)</cell><cell>0.76 (0.62e0.93)</cell></row><row><cell>Calcium antag. Monotx (n ¼ 4)</cell><cell>0.85 (0.81e1.11)</cell></row><row><cell>Beta antag. Monotx (n ¼ 18)</cell><cell>0.76 (0.59e0.97)</cell></row><row><cell>Diuretic Monotx (n ¼ 0)</cell><cell>NA</cell></row><row><cell>Other Monotx (n ¼ 1)</cell><cell>0.83 (NA)</cell></row><row><cell>Multiple antihypertensives (n ¼ 11)</cell><cell>0.78 (0.69e0.87)</cell></row><row><cell>TG metabolism (12 missing)</cell><cell></cell><cell>0.092 b</cell></row><row><cell>Fast (n ¼ 26)</cell><cell>0.90 (0.71e1.09)</cell></row><row><cell>Medium (n ¼ 50)</cell><cell>0.74 (0.59e0.87)</cell></row><row><cell>Slow (n ¼ 29)</cell><cell>0.78 (0.67e0.90)</cell></row><row><cell cols="3">Antag indicates antagonist; ARA II, angiotensin receptor 2 antagonists; ACE,</cell></row><row><cell cols="3">angiotensin converting enzyme; CAD, coronary artery disease; IMTmean, common</cell></row><row><cell cols="3">carotid intima-media thickness, average thickness between right and left artery;</cell></row><row><cell cols="3">IQR, interquartile range; Monotx, monotherapy; NA, not applicable; TG, tri-</cell></row><row><cell cols="2">glycerides; TOAST, Trial of Org 10172 in Acute Stroke Treatment.</cell></row><row><cell>a ManneWhitney U test.</cell><cell></cell></row><row><cell cols="2">b Ordinal regression (intima-media thickness log transformed).</cell></row><row><cell>c Kruskal Wallis test.</cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J. Batluk et al. / Atherosclerosis 243 (2015) 186e191</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>The research leading to these results has received funding from the Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin (01 E0 0801).</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of interest statement</head><p><s>None to declare.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Financial disclosures</head><p><s>JB, CL, UG, KSL, SJS, and Martin E have no conflicts of interest to declare.</s></p><p><s>Matthias E has received grant support from AstraZeneca and Sanofi, has participated in advisory board meetings of Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, MSD, Pfizer, Sanofi and has received honoraria from Astra Zeneca, Bayer, Berlin Chemie, Bristol-Myers Squibb, Boehringer-Ingelheim, Desitin, Eisei, Ever, Glaxo Smith Kline, MSD, Novartis, Pfizer, Sanofi, Takeda, Trommsdorff.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Appendix A. Supplementary data</head><p><s>Supplementary data related to this article can be found at http:// dx.doi.org/10.1016/j.atherosclerosis.2015.09.003.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">N</forename><surname>Hodis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Mack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Labree</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Selzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Alaupovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kwong-Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Azen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Intern. Med</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="548" to="e556" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Bots</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Hoes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Koudstaal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hofman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Grobbee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="1432" to="e1437" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>O'leary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Polak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Kronmal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Manolio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Burke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Wolfson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">340</biblScope>
			<biblScope unit="page" from="14" to="e22" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Groot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Van Stiphout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">H</forename><surname>Krauss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Jansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Van Tol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Van Ramshorst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chin-On</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Hofman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cresswell</surname></persName>
		</author>
		<author>
			<persName><surname>Havekes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler. Thromb. Vasc. Biol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="653" to="e662" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Postprandial lipemia, fenofibrate and coronary artery disease</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Williamson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Olivecrona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pringle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Maclean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Lorimer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bonnefous</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Bogaievsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Packard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Shepherd</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Atherosclerosis</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="193" to="e202" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Patsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Miesenbock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hopferwieser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Muhlberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Knapp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Dunn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Gotto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Patsch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler. Thromb. Vasc. Biol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1336" to="e1345" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men</title>
		<author>
			<persName><forename type="first">S</forename><surname>Boquist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ruotolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bjorkegren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Bond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>De Faire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Karpe</surname></persName>
		</author>
		<author>
			<persName><surname>Hamsten</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="723" to="e728" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Hell enius, Hamsten a. Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men</title>
		<author>
			<persName><forename type="first">F</forename><surname>Karpe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>De Faire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mercuri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Bond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Atherosclerosis</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="307" to="e314" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Ryu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Howard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Craven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Bond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Hagaman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Crouse</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="823" to="e828" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women. The Atherosclerosis Risk in Communities (ARIC) Study</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Sharrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Chambless</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Heiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Paton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Patsch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler. Thromb. Vasc. Biol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="2122" to="e2129" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Postprandial glucose and not triglyceride concentrations are associated with carotid intima media thickness in women with normal glucose metabolism: the Hoorn prandial study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Alssema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Schindhelm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Dekker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Diamant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Kostense</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Teerlink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Scheffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nijpels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Heine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Atherosclerosis</title>
		<imprint>
			<biblScope unit="volume">196</biblScope>
			<biblScope unit="page" from="712" to="e719" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Association of blood lipid and glucose levels with carotid intima media thickness</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bokhari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hanif</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Postgrad. Med. Inst</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="129" to="e135" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Cardiovascular risk in nonobese hypertensive adolescents: a study based on plasma biomarkers and ultrasonographic assessment of early atherosclerosis</title>
		<author>
			<persName><forename type="first">B</forename><surname>Głowi Nska-Olszewska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tołwi Nska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Łuczy Nski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Konstantynowicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bossowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Hum. Hypertens</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="191" to="e196" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
	</analytic>
	<monogr>
		<title level="m">Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease</title>
				<editor>
			<persName><forename type="first">J</forename><surname>Kotur-Stevuljevi C</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">A</forename><surname>Peco-Anti C</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">S</forename><surname>Spasi C</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">A</forename><surname>Stefanovi C</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">D</forename><surname>Paripovi C</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">M</forename><surname>Kosti C</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">D</forename><surname>Vasi C</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">A</forename><surname>Vujovi C</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Z</forename><surname>Jeli C-Ivanovi C</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">V</forename><surname>Spasojevi C-Kalimanovska</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">D</forename><surname>Kornic-Ristovski</surname></persName>
		</editor>
		<imprint>
			<date type="published" when="2013">2013</date>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="295" to="e303" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Ethnic differences in carotid intima-media thickness between UK children of black African-Caribbean and white European origin</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Whincup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Nightingale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Owen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rapala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Bhowruth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Prescott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Ellins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Donin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Masi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Rudnicka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sattar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Deanfield</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1747" to="e1754" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Segment-specific associations of carotid intima-media thickness with cardiovascular risk factors: the Coronary Artery Risk Development in Young Adults (CARDIA) study</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Polak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Person</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Godreau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Jacobs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Harrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sidney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>O'leary</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="9" to="e15" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">The echogenicity of the intimamedia complex in the common carotid artery is related to insulin resistance measured by the hyperinsulinemic clamp in elderly men</title>
		<author>
			<persName><forename type="first">L</forename><surname>Lind</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wohlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Andren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sundstr€</surname></persName>
		</author>
		<author>
			<persName><surname>Om</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Physiol. Funct. Imaging</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="137" to="e142" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment</title>
		<author>
			<persName><forename type="first">V</forename><surname>Manninen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tenkanen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Koskinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Huttunen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Manttari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">P</forename><surname>Heinonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Frick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="37" to="e45" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Rubins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Robins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Fye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Elam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Faas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Linares</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Schaefer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schectman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Wilt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wittes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">341</biblScope>
			<biblScope unit="page" from="410" to="e418" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Keech</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Simes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Barter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Best</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Taskinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Forder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pillai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Glasziou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Drury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">A</forename><surname>Kes€ Aniemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Colman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>D'emden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Whiting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ehnholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Laakso</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">366</biblScope>
			<biblScope unit="page" from="1849" to="e1861" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bansal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Buring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rifai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Sacks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Ridker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">298</biblScope>
			<biblScope unit="page" from="309" to="e316" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Nonfasting triglycerides and risk of ischemic stroke in the general population</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Freiberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tybjaerg-Hansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Nordestgaard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">300</biblScope>
			<biblScope unit="page" from="2142" to="e2152" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Fasting versus nonfasting triglycerides and the prediction of cardiovascular risk: do we need to revisit the oral triglyceride tolerance test?</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Ridker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Chem</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="11" to="e13" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Cream &amp; Sugar&quot; Study: the prognostic impact of an oral triglyceride tolerance test in patients after acute ischaemic stroke</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ebinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">U</forename><surname>Heuschmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Jungehuelsing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Werner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Laufs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Endres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">The</forename><surname>Berlin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Stroke</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="126" to="e130" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Bendixen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Kappelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Biller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Love</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Gordon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Marsh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="35" to="e41" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">NIH Image to ImageJ: 25 years of image analysis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Rasband</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Eliceiri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Methods</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="671" to="e675" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<author>
			<persName><forename type="first">P.-J</forename><surname>Touboul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Hennerici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Meairs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Amarenco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bornstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Csiba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Desvarieux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ebrahim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jaff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kownator</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Naqvi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Prati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rundek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Sitzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-C</forename><surname>Schminke</surname></persName>
		</author>
		<author>
			<persName><surname>Tardif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Vicaut</surname></persName>
		</author>
		<author>
			<persName><surname>Woo</surname></persName>
		</author>
		<title level="m">An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences</title>
				<meeting><address><addrLine>Mannheim, Germany</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2004">2004-2006-2011. 2004. 2012</date>
			<biblScope unit="page" from="290" to="e296" />
		</imprint>
	</monogr>
	<note>Mannheim carotid intima-media thickness and plaque consensus. B, Cerebrovasc. Dis. 34</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">National Kidney Foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Kopple</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="S66" to="S70" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Atherogenesis: a postprandial phenomenon</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Zilversmit</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="473" to="e485" />
			<date type="published" when="1979">1979</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Weinstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Castellani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Walzem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Lusis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Fong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Beigneux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Young</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Chylomicronemia elicits atherosclerosis in miceebrief report</title>
				<imprint>
			<date type="published" when="2010">2010</date>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="20" to="e23" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Lipolysis needed for chylomicron uptake?</title>
		<author>
			<persName><forename type="first">S</forename><surname>Parthasarathy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler. Thromb. Vasc. Biol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="5" to="e6" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Induction of atherosclerosis by human chylomicron remnants: a hypothesis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Wilhelm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Cooper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Atheroscler. Thromb</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="132" to="e139" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Risk prediction with triglycerides in patients with stable coronary disease on statin treatment</title>
		<author>
			<persName><forename type="first">C</forename><surname>Werner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Filmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fritsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Groenewold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gr€ Aber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>B€ Ohm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Laufs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Res. Cardiol</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="984" to="e997" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Lipoprotein phenotype and adhesion molecules correlate with diurnal triglyceride profiles in patients with coronary artery disease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Schmidt-Trucks€ Ass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Baumstark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Daub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Espenschied</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Grathwohl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Berg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nutr. Metab. Cardiovasc. Dis</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="20" to="e25" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
